2026-01-13
Bloomberg
3 related
NYC-based Proxima, which uses AI to design drugs that control protein interactions, raised an $80M seed led by DCVC; Nvidia, Roivant, and Braidwell invested too
Proxima, a biotech startup using artificial intelligence to design drugs that control protein interactions, raised $80 million in seed funding …
Loading articles...